Publications by authors named "Michael A Pfaller"

Claim this Profile
E
Evaluation of the Activity of Triazoles Against Non- and Cryptic Species Causing Invasive Infections Tested in the SENTRY Program.
Michael A Pfaller, Cecilia G Carvalhaes, Paul R Rhomberg, Abigail Klauer, Mariana Castanheira

Open Forum Infect Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of isavuconazole antifungal medicine to treat mold infections in Asia and the Western Pacific region: a plain language summary.
Michael A Pfaller, Cecilia G Carvalhaes, Paul R Rhomberg, Mariana Castanheira

Future Microbiol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain language summary: Did the COVID-19 pandemic change the resistance to current antifungal medicines?
Michael A Pfaller, Cecilia G Carvalhaes, Sean DeVries, Paul R Rhomberg, Mariana Castanheira

Future Microbiol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A plain language summary of how some fungi samples that show resistance to antifungal medicines have changes in their genes.
Mariana Castanheira, Timothy D Collingsworth, Andrew P Davis, Lalitagauri M Deshpande, Michael A Pfaller

Future Microbiol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in the susceptibility of U.S. species complex and isolates to minocycline, 2014-2021.
Michael A Pfaller, Dee Shortridge, Cecilia G Carvalhaes, Mariana Castanheira

Microbiol Spectr· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018-2021) and application of single-site epidemiological cutoff values to evaluate amphotericin B activity.
Michael A Pfaller, Cecilia G Carvalhaes, Mariana Castanheira

Mycoses· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against with and without CYP51 Alterations.
Michael A Pfaller, Cecilia G Carvalhaes, Lalitagauri M Deshpande, Paul R Rhomberg, Mariana Castanheira

J Fungi (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific.
Cecilia G Carvalhaes, Paul R Rhomberg, Michael D Huband, Michael A Pfaller, Mariana Castanheira

J Fungi (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Post-Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata.
Cecilia G Carvalhaes, Paul R Rhomberg, Michael A Pfaller, Jeffrey B Locke, Mariana Castanheira

Mycoses· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Collaborative Study of the Interaction of Antifungal Combinations against Spp. by Loewe Additivity and Bliss Independence-Based Response Surface Analysis.
Joseph Meletiadis, David R Andes, Shawn R Lockhart, Mahmoud A Ghannoum, Cindy C Knapp, Michael A Pfaller

J Fungi (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain language summary: Does a person's age affect how common fungal infections are and how well drugs can kill the infections?
Michael A Pfaller, Cecilia G Carvalhaes, Sean DeVries, Michael D Huband, Mariana Castanheira

Future Microbiol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftobiprole activity against Gram-positive and Gram-negative pathogens causing bone and joint infections in the United States from 2016 to 2020.
Leonard R Duncan, Kamal A Hamed, Jennifer I Smart, Michael A Pfaller, Robert K Flamm

Diagn Microbiol Infect Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpression.
Mariana Castanheira, Lalitagauri M Deshpande, Andrew P Davis, Cecilia G Carvalhaes, Michael A Pfaller

J Glob Antimicrob Resist· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections.
Michael A Pfaller, Cecilia G Carvalhaes, Sean DeVries, Paul R Rhomberg, Mariana Castanheira

Med Mycol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017-2019.
Michael A Pfaller, Cecilia G Carvalhaes, Sean DeVries, Michael D Huband, Mariana Castanheira

Diagn Microbiol Infect Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Rezafungin Provisional CLSI Clinical Breakpoints and Epidemiological Cutoff Values Tested against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019 to 2020).
Cecilia G Carvalhaes, Abby L Klauer, Paul R Rhomberg, Michael A Pfaller, Mariana Castanheira

J Clin Microbiol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019).
Michael A Pfaller, Cecilia G Carvalhaes, Paul Rhomberg, Shawn A Messer, Mariana Castanheira

J Antibiot (Tokyo)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019.
Michael A Pfaller, Michael D Huband, Dee Shortridge, Robert K Flamm

J Glob Antimicrob Resist· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
activity of a novel aminomethylcycline antibacterial (KBP-7072), a third-generation tetracycline, against clinical isolates with molecularly characterized tetracycline resistance mechanisms.
Michael A Pfaller, Li Li, Qingmei Liu, Jay Zhang, Michael D Huband

JAC Antimicrob Resist· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
Michael A Pfaller, Cecilia G Carvalhaes, Shawn A Messer, Paul R Rhomberg, Mariana Castanheira

Diagn Microbiol Infect Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015-2018.
Michael A Pfaller, Dee Shortridge, Kelly A Harris, Mark W Garrison, C Andrew DeRyke

Int J Infect Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isavuconazole nonwildtype Aspergillus fumigatus isolates from a global surveillance study display alterations in multiple genes involved in the ergosterol biosynthesis pathway not previously associated with resistance to other azoles.
Mariana Castanheira, Timothy D Collingsworth, Andrew P Davis, Lalitagauri M Deshpande, Michael A Pfaller

Mycoses· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018-2019).
Michael A Pfaller, Michael D Huband, Robert K Flamm, Paul A Bien, Mariana Castanheira

J Glob Antimicrob Resist· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019).
Michael A Pfaller, Cecilia G Carvalhaes, Paul Rhomberg, Shawn A Messer, Mariana Castanheira

J Antibiot (Tokyo)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antifungal drugs work together to treat germs causing fungal infections.
Michael A Pfaller, Shawn A Messer, Lalitagauri M Deshpande, Paul R Rhomberg, Eric A Utt

Future Microbiol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis